Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease.

Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease.

The management of Crohn's disease is rapidly changing. The advent of potent immunomodulatory and biologic therapies has led to more demanding endpoints for clinical trials than only clinical response and remission. Complete withdrawal of corticosteroids, healing of endoscopically visible lesion...

תיאור מלא

מידע ביבליוגרפי
Main Authors:	D'Haens, G, Fedorak, R, Lémann, M, Feagan, BG, Kamm, M, Cosnes, J, Rutgeerts, P, Marteau, P, Travis, S, Schölmerich, J, Hanauer, S, Sandborn, W
פורמט:	Journal article
שפה:	English
יצא לאור:	2009

פריטים דומים

Central Reading of Endoscopy Endpoints in Inflammatory Bowel Disease Trials.
מאת: Gottlieb, K, et al.
יצא לאור: (2015)

Evolving concepts in phases I and II drug development for Crohn's Disease
מאת: Jairath, V, et al.
יצא לאור: (2016)

Development of the Paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion process.
מאת: Peyrin-Biroulet, L, et al.
יצא לאור: (2012)

Development of the Crohn's disease digestive damage score, the Lemann score.
מאת: Pariente, B, et al.
יצא לאור: (2011)

A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998.
מאת: Gasche, C, et al.
יצא לאור: (2000)

Evolving concepts in Phase I and II Drug Development for Crohn's Disease.
מאת: Jairath, V, et al.
יצא לאור: (2016)

American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006.
מאת: Clark, M, et al.
יצא לאור: (2007)

The Crohn's disease–ulcerative colitis clinical appraisal update: emerging trends in clinical practice
מאת: Sandborn, W, et al.
יצא לאור: (2016)

The future of inflammatory bowel disease management: combining progress in trial design with advances in targeted therapy.
מאת: Travis, S, et al.
יצא לאור: (2012)

European evidence based consensus on the diagnosis and management of Crohn's disease: current management.
מאת: Travis, S, et al.
יצא לאור: (2006)

Biomarker correlation with endoscopic outcomes in patients with Crohn's disease: data from CALM
מאת: Reinisch, W, et al.
יצא לאור: (2018)

Management of Perianal Crohn's Disease
מאת: Paul Rutgeerts
יצא לאור: (2000-01-01)

Development of red flags index for early referral of adults with symptoms and signs suggestive of Crohn’s disease: an IOIBD initiative
מאת: Danese, S, et al.
יצא לאור: (2015)

Steroid-Dependent Crohn’s Disease
מאת: William J Sandborn
יצא לאור: (2000-01-01)

Infliximab in the Treatment of Crohn’s Disease
מאת: Brian Feagan
יצא לאור: (2000-01-01)

Characterization of Mucosal Lesions in Crohn's Disease Scored With Capsule Endoscopy: A Systematic Review
מאת: Miquel Marquès Camí, et al.
יצא לאור: (2021-01-01)

Standardizing scoring conventions for Crohn’s disease endoscopy: An international RAND/UCLA appropriateness study
מאת: Khanna, R, et al.
יצא לאור: (2023)

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial.
מאת: Colombel, J, et al.
יצא לאור: (2017)

Placebo response and remission rates in randomised trials of induction and maintenance therapy for Crohn's disease
מאת: Jairath, V, et al.
יצא לאור: (2016)

Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS).
מאת: Travis, S, et al.
יצא לאור: (2012)

Biosimilars in IBD: hope or expectation?
מאת: Gecse, K, et al.
יצא לאור: (2013)

Risk Factors for Relapse and Recurrence of Ulcerative Colitis and Crohn’s Disease
מאת: Paul Rutgeerts
יצא לאור: (1993-01-01)

Reliability among central readers in the evaluation of endoscopic disease activity in pouchitis
מאת: Samaan, MA, et al.
יצא לאור: (2018)

Biologic Therapies: From Complexity to Clinical Practice in a Changing Environment
מאת: Remo Panaccione, et al.
יצא לאור: (2015-12-01)

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?
מאת: D'Haens, G, et al.
יצא לאור: (2011)

Osteoporosis of Crohn’s Disease: A Critical Review
מאת: Neena S Abraham, et al.
יצא לאור: (1996-01-01)

Oropharyngeal Crohn&rsquo;s disease
מאת: Rachid Mohamed, et al.
יצא לאור: (2008-12-01)

Tight control for Crohn's disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial
מאת: Panaccione, R, et al.
יצא לאור: (2019)

Central Endoscopy Reading in Inflammatory Bowel Diseases
מאת: Panés, J, et al.
יצא לאור: (2016)

Misleading pustular plaques of the lower limbs during Crohn's disease: two case reports
מאת: Farhi David, et al.
יצא לאור: (2007-10-01)

Does Smoking Reduce Infliximab’s Effectiveness against Crohn’s Disease?
מאת: Neeraj Narula, et al.
יצא לאור: (2009-01-01)

European evidence-based Consensus on the management of ulcerative colitis: Current management.
מאת: Travis, S, et al.
יצא לאור: (2008)

Reliability and initial validation of the ulcerative colitis endoscopic index of severity.
מאת: Travis, S, et al.
יצא לאור: (2013)

The Impact of Clinical Information on the Assessment of Endoscopic Activity: Characteristics of the Ulcerative Colitis Endoscopic Index Of Severity [UCEIS].
מאת: Travis, S, et al.
יצא לאור: (2015)

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.
מאת: Van Assche, G, et al.
יצא לאור: (2010)

Genotype/phenotype analyses for 53 Crohn's disease associated genetic polymorphisms.
מאת: Camille Jung, et al.
יצא לאור: (2012-01-01)

Predicting, Treating and Preventing Postoperative Recurrence of Crohn’s Disease: The State of the Field
מאת: Anna M Borowiec, et al.
יצא לאור: (2011-01-01)

Crohn’s disease or Crohn’s diseases?
מאת: Arnott, IDR, et al.
יצא לאור: (2003)

The genetic prediction of the clinical response to infliximab in Crohn's disease (CD): A role for polymorphisms in the TNFa and LTA genes?
מאת: De Silva, A, et al.
יצא לאור: (2002)

Intestinal fibrosis is associated with lack of response to Infliximab therapy in Crohn's disease.
מאת: Jessica R de Bruyn, et al.
יצא לאור: (2018-01-01)